Pharmacogenomics & Genomics Executive Search

Pharmacogenomics and genomics are reshaping the future of medicine. By connecting genetic insights to patient outcomes, these fields are the foundation of precision medicine and play a central role in advancing diagnostics and personalized care. The demand for executives with deep expertise in these areas is accelerating, as pharmaceutical and biotech companies compete to build leadership teams capable of translating new science into breakthrough therapies.

Klein Hersh recruits the visionary executives who drive pharmacogenomics and genomics innovation, helping organizations turn cutting-edge research into patient-ready treatments. With over 25 years of experience in pharma/biotech executive search, we understand the specialized leadership required to advance discovery in this rapidly evolving space.

The Strategic Role of Pharmacogenomics & Genomics Leaders

Executives in pharmacogenomics and genomics are scientific and strategic leaders who:

  • Guide discovery and development programs linking genetic data to therapeutic impact
  • Lead genomic research platforms that support drug discovery, biomarker development, and diagnostics
  • Build cross-functional teams spanning R&D, translational medicine, and clinical development
  • Drive partnerships with technology providers, research institutions, and healthcare systems
  • Translate genomic insights into strategies for precision medicine and personalized therapies

Without the right leadership, innovation risks stalling at the research stage. With the right executives, organizations can accelerate the development of exciting, new therapies.

The Klein Hersh Advantage in Pharmacogenomics & Genomics Search

At Klein Hersh, we specialize in connecting clients with leaders at the forefront of scientific discovery. Our biotech and pharmaceutical recruiting team:

  • Delivers access to a global network of trusted pharmacogenomics and genomics executives
  • Maintains long-standing relationships across pharma, biotech, and academic research
  • Tailors every search to organizational mission, culture, and scientific priorities
  • Partners with early-stage ventures, established companies, and investors to build leadership teams that drive growth

Because we are immersed in the life sciences marketplace, we recognize not just technical expertise but the visionary leadership that turns discovery into impact. Our relationship-centered approach ensures every placement strengthens culture and accelerates innovation.

TO QUOTE AN EXPERTAs the industry’s trusted team of pharmaceutical recruiters, We at Klein Hersh are uniquely suited to fulfill highly specialized executive search requirements across the entire life sciences and healthcare continuum.

Pharmacogenomics & Genomics Recruiting with Impact

From groundbreaking biomarker discovery to next-generation personalized medicine strategies, leaders in pharmacogenomics and genomics are shaping the future of healthcare. Klein Hersh connects companies with the executives whose expertise and foresight transform research into therapies that reach patients and create lasting advantage.



 

 



Building Long-Term Talent Partnerships in Private Equity
Summary: Since 2019, Klein Hersh has partnered with a leading healthcare-focused private equity firm to build executive leadership teams across its portfolio. Over five years, this relationship has evolved from an initial talent-sharing introduction into a trusted, strategic partnership spanning nine portfolio companies and more than 20 executive placements, including CEOs, commercial officers, operating partners, and advisors. Klein Hersh’s deep ...
By Michael Frank
January 12, 2026
JPM 2026: Why This Feels Like a Turning Point for Biotech and Pharma Leadership 
Heading into JPM this year, the difference was immediately noticeable. After several years defined by caution and constraint, JPM 2026 felt like a turning point. The conversations our team had with CEOs, CMOs, Board Members and investors reflected a level of optimism and urgency we have not experienced since 2021.  While no one is calling this a boom, there is genuine conviction ...
By Josh Albert
January 21, 2026
PharmaVoice Interview: Executive Hiring Changes Reflect a Broader Biotech Comeback 
Read Alexandra Pecci’s article in PharmaVoice: Executive hiring changes reflect a broader biotech comeback. Executive hiring shifts are often indicators of wider trends in the market. Here’s how the hiring landscape for pharma leaders is changing. The biotech market is still in recovery mode, with the number of IPOs gradually rising in the years since 2022’s dismal low. That upward trend is ...
By Jason Hersh
January 30, 2025
Klein Hersh Taps Healthcare Industry Veteran to Elevate Growing Healthcare Recruitment Practice 
March 26, 2025 – Horsham, PA. Klein Hersh, a precision executive search firm specializing in life sciences and healthcare, is pleased to announce the appointment of industry veteran Neil Ravitz as Vice President, Healthcare.   Neil brings 17+ years of executive healthcare leadership experience to Klein Hersh, having driven operational and financial success in some of the nation’s leading healthcare institutions. ...
By Klein Hersh
March 25, 2025